NCT04803734View on ClinicalTrials.gov

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

May 10, 2021

Study Completion Date

May 14, 2021

Conditions
Healthy
Interventions
DRUG

Albuterol Sulfate inhalation aerosol 108mcg per actuation

MDI, 2 puffs, single dose, fasting

DRUG

Proair HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation

MDI, 2 puffs, single dose, fasting

Trial Locations (1)

251

Tamshui Mackay Memorial Hospital, New Taipei City

Sponsors
All Listed Sponsors
lead

Intech Biopharm Ltd.

INDUSTRY

NCT04803734 - Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter